Search Results 581-590 of 17810 for Coagulate

  1. Drugs and Supplements that Start with R - Mayo Clinic

    Also known as. Interferon beta-1a (intramuscular route, subcutaneous route). Rebinyn. Also known as. Coagulation factor ix recombinant, glycopegylated ( ...

  2. Phase 3 Study of PDS0101 and Pembrolizumab in HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma - Mayo Clinic

    Coagulation: INR, prothrombin time (PT) ≤1.5 × ULN; if subject is receiving anticoagulant therapy, INR or PT- should be within therapeutic range of ...

  3. 18 Months Later - Your Impact Development

    We did the genetic testing and found out, in fact, Andrew was not able to break down the medications the way most individuals would. Because of this, the ...

  4. Oncology (Medical) - Doctors - Mayo Clinic

    ... coagulation, Bleeding disorder, Benign hematologic condition, Autoimmune hemolytic anemia, Paroxysmal nocturnal hemoglobinuria, Myeloproliferative disorders ...

  5. TRC-PAD Program: In-Clinic Trial-Ready Cohort

    ... coagulation (e.g. warfarin). Participants whom the Site PI deems to be otherwise ineligible. Participating Mayo Clinic locations. Study statuses change often ...

  6. A Study Evaluating Effectiveness and Safety of FFX Versus Combination of CPI-613 with mFFX in Patients with Metastatic Adenocarcinoma of the Pancreas - Mayo Clinic

    Adequate coagulation function: International Normalized Ratio or INR must be <1.5 unless on therapeutic blood thinners). Bilirubin less than or equal to 1.5x ...

  7. Cardiovascular Medicine - Clinical trials

    The purpose of this study is to describe the clinical impact of cardiac rehabilitation in patients who have undergone myectomy for hypertrophic ...

  8. A Study of 9-ING-41 in Patients with Advanced Cancers - Mayo Clinic

    Adequate blood coagulation: international normalized ratio (INR) ≤ 2.3 5. Serum amylase and lipase ≤ 1.5 x ULN 6. Has adequate performance status (PS): ...

  9. Gastroenterology and Hepatology - Clinical trials

    Rochester, Minn. Gastrointestinal (GI) infection with Campylobacter causes inflammation in the bowel and can change bacteria in the gut. Certain individuals ...

  10. A Study to Evaluate Mesenchymal Stem Cells to Treat Multiple System Atrophy - Mayo Clinic

    ... coagulation, and patients on active anticoagulation. Participants who have taken any investigational products within 90 days prior to baseline, or with ...